Patents by Inventor Alberto Anel

Alberto Anel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS SELECTIVELY TARGETING HIGHLY GLYCOLYTIC TUMOR CELLS AND METHODS THEREOF
    Publication number: 20240009212
    Abstract: A cellular model with a highly glycolytic phenotype (L929dt cells) for study of phosphaplatin-based anticancer agents, in particular (R,R)-1,2-cyclohexanediamine-(pyrophosphato) platinum(II) (or “PT-112”), is disclosed. The expression of HIF-1? as a biomarker of glycolytic cells sensitive to PT-112, clinical applications of the biomarker, and methods thereof for diagnosis and treatment of patients with cancers are disclosed.
    Type: Application
    Filed: October 20, 2021
    Publication date: January 11, 2024
    Applicant: Promontory Therapeutics Inc.
    Inventors: Tyler D. Ames, Alberto Anel
  • Granulysin, method of obtaining same, and uses
    Patent number: 11858973
    Abstract: The present invention relates to granulysin, method of obtaining same, and uses, specifically to the granulysin polypeptide for the use thereof as a medicinal product via the systemic route and to a chimeric molecule comprising a recombinant antibody targeting a tumor antigen and the granulysin polypeptide.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: January 2, 2024
    Assignees: UNIVERSIDAD DE ZARAGOZA, FUNDACIÓN AGENCIA ARAGONESA PARA LA INVESTIGACIÓN Y EL DESARROLLO (ARAID), FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA
    Inventors: Luis Alberto Anel Bernal, Raquel Ibañez Perez, Patricia Guerrero Ochoa, Luis Martinez Lostao, Blanca Conde Guerri, Ramón Hurtado Guerrero, Ana Laura Sanz Alcober, Rocio Navarro Ortiz
  • GRANULYSIN, METHOD OF OBTAINING SAME, AND USES
    Publication number: 20210340196
    Abstract: The present invention relates to granulysin, method of obtaining same, and uses, specifically to the granulysin polypeptide for the use thereof as a medicinal product via the systemic route and to a chimeric molecule comprising a recombinant antibody targeting a tumor antigen and the granulysin polypeptide.
    Type: Application
    Filed: July 24, 2019
    Publication date: November 4, 2021
    Inventors: Luis Alberto ANEL BERNAL, Raquel IBAÑEZ PEREZ, Patricia GUERRERO OCHOA, Luis MARTINEZ LOSTAO, Blanca CONDE GUERRI, Ramón HURTADO GUERRERO, Ana Laura SANZ ALCOBER, Rocio NAVARRO ORTIZ
  • Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein
    Publication number: 20120189690
    Abstract: The invention relates to the field of biotechnology and medicine. The invention specifically relates to a compound comprising a liposome covered or decorated at least with the extracellular domain of the APO2L/TRAIL protein, and to the use thereof far developing a medicament preferably for the treatment of a cancer or inflammatory or autoimmune diseases, such as rheumatoid arthritis.
    Type: Application
    Filed: August 12, 2010
    Publication date: July 26, 2012
    Applicants: Universidad De Zaragoza, Consejo Superior De Investigaciones Cientificas, Universidad Del Pais Vasco/Euskal Herriko Unibertsitatea
    Inventors: Luis Alberto Anel Bernal, Maria Jose Martinez Lorenzo, Luis Martinez Lostao, Maria Angeles Alava Martinez De Contrasta, Luis Larrad Mur, Javier Naval Iraberri, Andres Pineiro Anton, Gorka Basanez Asua